Healthcare - Biotechnology - NASDAQ - US
$ 7.62
-1.04 %
$ 58.5 M
Market Cap
19.54
P/E
BALANCE SHEET
160 M
ASSETS
141 M
LIABILITIES
18.9 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Precision BioSciences, Inc.
| Current Assets | 136 M |
| Cash & Short-Term Investments | 117 M |
| Receivables | 12.8 M |
| Other Current Assets | 6.88 M |
| Non-Current Assets | 23.4 M |
| Long-Term Investments | 8.2 M |
| PP&E | 14.6 M |
| Other Non-Current Assets | 625 K |
| Current Liabilities | 50 M |
| Accounts Payable | 2.97 M |
| Short-Term Debt | 23.5 M |
| Other Current Liabilities | 23.5 M |
| Non-Current Liabilities | 90.9 M |
| Long-Term Debt | 7.72 M |
| Other Non-Current Liabilities | 83.2 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash & Cash Equivalents | 116.7 | 189.6 | 143.7 | 89.8 | 180.9 | 103.2 | 62.8 | 93.4 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 12.8 | 0.7 | 0.5 | 10.0 | 1.0 | 0.5 | 22 K | 0.4 |
| Inventory | 0 | 7.6 | 17.4 | 5.8 | 9.5 | 0 | 0 | 0 |
| Other Current Assets | 6.9 | 8.8 | 17.6 | 5.8 | 11.8 | 12.0 | 1.5 | 0.6 |
| Total Current Assets | 136.4 | 199.1 | 161.8 | 105.6 | 193.7 | 115.7 | 64.3 | 94.4 |
| PP&E | 14.6 | 23.2 | 29.3 | 41.5 | 39.6 | 21.1 | 8.1 | 3.5 |
| Intangible Assets | 0.4 | 1.3 | 2.0 | 1.4 | 1.4 | 1.5 | 90 K | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 8.2 | 4.7 | 6.8 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.2 | 9.8 | 4.6 | 1.7 | 0.6 | 0.3 | 0.1 | 0.5 |
| Other Assets | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 159.8 | 238.2 | 211.5 | 150.2 | 235.2 | 138.6 | 72.7 | 98.4 |
| LIABILITIES | ||||||||
| Accounts Payable | 3.0 | 0.7 | 1.1 | 0.8 | 2.0 | 2.2 | 1.8 | 1.3 |
| Short Term Debt | 23.5 | 1.7 | 3.6 | 3.9 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 11.4 | 11.1 | 9.9 | 7.9 | 8.4 | 3.4 | 1.6 | 0.8 |
| Total Current Liabilities | 50.0 | 59.7 | 36.0 | 42.8 | 26.9 | 14.1 | 9.2 | 8.3 |
| Long Term Debt | 7.7 | 23.3 | 7.3 | 8.6 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.1 | 1.9 | 44 K | 0.4 | 4.1 | 1.8 | 1.3 | 0.4 |
| Total Liabilities | 140.9 | 177.7 | 120.3 | 105.7 | 96.9 | 98.6 | 99.1 | 103.2 |
| EQUITY | ||||||||
| Common Stock | 1 K | 1 K | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (489.6) | (428.3) | (316.7) | (286.1) | (177.1) | (85.2) | (39.1) | (18.0) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | 0 | 0 | (5.5) | (3.2) | 0 |
| Total Equity | 18.9 | 60.4 | 91.2 | 44.4 | 138.3 | 40.0 | (26.4) | (4.7) |
| Total Liabilities and Equity | 159.8 | 238.2 | 211.5 | 150.2 | 235.2 | 138.6 | 72.7 | 98.4 |
| SHARES OUTSTANDING | ||||||||
| Common Shares Outstanding | 3.8 | 2.9 | 2.0 | 1.7 | 1.4 | 1.6 | 1.1 | 1 673.8 |